Manish Sharad Parikh

Reported credentials

• Surgery Source ↗

Source-reported information; confirm current details directly.

Selected publications

• Building the Business Case for Access to Obesity Treatment. · 2026 Source ↗
• Management of portomesenteric vein thrombosis following bariatric surgery. · 2026 Source ↗
• Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide. · 2026 Source ↗
• Conversion of endoscopic sleeve gastroplasty to bariatric surgery. · 2026 Source ↗
• Real-World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery. · 2026 Source ↗
• Quality of life and clinical outcomes after large-bore mechanical thrombectomy for submassive pulmonary embolism. · 2026 Source ↗
• Impact of Prior Bariatric Surgery Versus Immediate Total Knee Arthroplasty on Knee Function Among Patients Who Have Severe Obesity and Advanced Knee Osteoarthritis: The SWIFT Trial. · 2026 Source ↗
• Semaglutide vs. Bariatric Surgery: Comparing Costs and Clinical Outcomes in Patients With Diabetes and Obesity. · 2026 Source ↗
• Changes in Commercial Payments Following Ventral Hernia Billing Reform. · 2026 Source ↗
• Resting Energy Expenditure and Metabolic Adaptation Following Sleeve Gastrectomy in Hispanic Adults with Obesity. · 2026 Source ↗
• Efficacy and safety of direct oral anticoagulants versus enoxaparin for extended thromboprophylaxis following sleeve gastrectomy. · 2026 Source ↗
• Bariatric surgery vs. GLP-1 receptor agonists among primarily medicare and medicaid patients with diabetes: a 3-year analysis. · 2026 Source ↗
• Psychometric properties of the Eating loss of control scale in a sample of Hispanic persons seeking metabolic and bariatric surgery. · 2026 Source ↗
• Strategies for Conservative Management of Early Post-Operative Obstruction Following Roux-en-Y Gastric Bypass. · 2025 Source ↗
• Sleeve-to-bypass conversion vs. sleeve-with-adjuvant GLP-1 receptor agonists: an academic multicenter retrospective study. · 2025 Source ↗
• Characterizing the effect of bariatric surgery on circulating S100A9. · 2025 Source ↗
• Variations in weight loss and glycemic outcomes after sleeve gastrectomy by race and ethnicity. · 2025 Source ↗
• Sudden Cardiac Arrest in a Young Male: The Role of Intraplaque Hemorrhage and Coronary Spasm. · 2025 Source ↗
• Real-World Evaluation of PCI Guidance Using Dynamic Coronary Roadmap: A DCR4Contrast Trial Secondary Analysis. · 2025 Source ↗
• High-Density Lipoprotein Lipid and Protein Cargo and Cholesterol Efflux Capacity Before and After Bariatric Surgery. · 2025 Source ↗
• BE-CALM: a clinical score to predict weight loss after conversion from sleeve gastrectomy to Roux-en-Y gastric bypass. · 2025 Source ↗
• Cohort profile: study design and baseline characteristics of an observational longitudinal weight loss cohort and biorepository of patients undergoing sleeve gastrectomy in the USA. · 2024 Source ↗
• Gastrogastric and Gastroduodenal Intussusception After Gastric Plication. · 2024 Source ↗
• Comparison of Postoperative Bleed Rates and Location of Bleed Between Vessel Sealing Devices after Laparoscopic Sleeve Gastrectomy. · 2025 Source ↗
• Changes in Widespread Pain After Surgical Weight Loss in Racialized Adults: A Secondary Analysis From a 2-Year Longitudinal Study. · 2024 Source ↗
• Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. · 2024 Source ↗
• Routine extended (30 days) chemoprophylaxis for patients undergoing laparoscopic sleeve gastrectomy may reduce Portomesenteric vein thrombosis rates. · 2024 Source ↗
• Accuracy of Ultrasound Imaging for Etiology of New-Onset Painless Jaundice. · 2023 Source ↗
• Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial. · 2023 Source ↗
• Factor structure and measurement invariance of the English- versus Spanish-language Eating Disorder Examination Questionnaire: Brief Form (S-EDE-Q-BF) in Hispanic/Latino/a/x persons seeking bariatric surgery. · 2023 Source ↗
• Bariatric surgery normalizes diabetes risk index by one month post-operation. · 2023 Source ↗
• Relation of Left Ventricular Hypertrophy Subtype to Long-Term Mortality in Those With Subclinical Cardiovascular Disease (from the Multiethnic Study of Atherosclerosis [MESA]). · 2022 Source ↗
• Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis. · 2022 Source ↗
• Re-do Laparoscopic Gastrojejunostomy for Gastrojejunal Anastomosis Stricture After Roux-en-Y Gastric Bypass. · 2021 Source ↗
• Meta-Analysis of Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease. · 2021 Source ↗
• Meta-Analysis of Transradial vs Transfemoral Access for Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction. · 2021 Source ↗
• Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry. · 2021 Source ↗
• Acute Care Surgeons' Response to the COVID-19 Pandemic: Observations and Strategies From the Epicenter of the American Crisis. · 2020 Source ↗
• Hemobilia as a Complication of Transhepatic Percutaneous Biliary Drainage: a Rare Indication for Laparoscopic Common Bile Duct Exploration. · 2020 Source ↗
• Small airway function in obese individuals with self-reported asthma. · 2020 Source ↗
• Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery. · 2020 Source ↗
• Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft. · 2020 Source ↗
• Thrombophilia prevalence in patients seeking laparoscopic sleeve gastrectomy: extended chemoprophylaxis may decrease portal vein thrombosis rate. · 2020 Source ↗
• Long-term outcomes comparing metabolic surgery to no surgery in patients with type 2 diabetes and body mass index 30-35. · 2020 Source ↗
• The Impact of Peripheral Artery Disease in Chronic Total Occlusion Percutaneous Coronary Intervention (Insights From PROGRESS-CTO Registry). · 2020 Source ↗
• Examining Food Addiction and Acculturation Among a Hispanic Bariatric Surgery-Seeking Participant Group. · 2019 Source ↗
• Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention. · 2020 Source ↗
• Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry. · 2019 Source ↗
• In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery. · 2019 Source ↗
• Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry). · 2019 Source ↗
• Severe obesity and bariatric surgery alter the platelet mRNA profile. · 2019 Source ↗
• Elevated GlycA in severe obesity is normalized by bariatric surgery. · 2019 Source ↗
• Lack of Diagnosis of Pneumoperitoneum in Perforated Duodenal Ulcer After RYGB: a Short Case Series and Review of the Literature. · 2018 Source ↗
• Bariatric Surgery and Time to Total Joint Arthroplasty: Does It Affect Readmission and Complication Rates? · 2018 Source ↗
• In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure. · 2018 Source ↗
• The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry. · 2018 Source ↗
• American Society for Metabolic and Bariatric Surgery review of the literature on one-anastomosis gastric bypass. · 2018 Source ↗
• Performance of the DiaRem Score for Predicting Diabetes Remission in Two Health Systems Following Bariatric Surgery Procedures in Hispanic and non-Hispanic White Patients. · 2018 Source ↗
• Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent. · 2018 Source ↗
• Changes in lipoprotein(a) following bariatric surgery. · 2018 Source ↗
• Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis). · 2017 Source ↗
• Factor VIII elevation may contribute to portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy: a multicenter review of 40 patients. · 2017 Source ↗
• Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention. · 2017 Source ↗
• Pregnancy after bariatric surgery: the effect of time-to-conception on pregnancy outcomes. · 2017 Source ↗
• Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions. · 2017 Source ↗
• Predictors of Excess Patient Radiation Exposure During Chronic Total Occlusion Coronary Intervention: Insights From a Contemporary Multicentre Registry. · 2017 Source ↗
• Preoperative Endoscopy Prior to Bariatric Surgery: a Systematic Review and Meta-Analysis of the Literature. · 2016 Source ↗
• Laparoscopic Treatment of Intussusception after Roux-en-Y Gastric Bypass. · 2017 Source ↗
• Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. · 2016 Source ↗
• Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry. · 2016 Source ↗
• Pulmonary Vascular Congestion: A Mechanism for Distal Lung Unit Dysfunction in Obesity. · 2016 Source ↗
• Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry. · 2016 Source ↗
• Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry. · 2017 Source ↗
• Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30-35. The role of sRAGE biomarker as predictor of satisfactory outcomes. · 2016 Source ↗
• ASMBS position statement on alcohol use before and after bariatric surgery. · 2016 Source ↗
• Insurance-mandated medical weight management before bariatric surgery. · 2016 Source ↗
• The utility of radiological upper gastrointestinal series and clinical indicators in detecting leaks after laparoscopic sleeve gastrectomy: a case-controlled study. · 2016 Source ↗
• Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. · 2015 Source ↗
• Intraoperative leak testing has no correlation with leak after laparoscopic sleeve gastrectomy. · 2016 Source ↗
• Bariatric Surgery versus Intensive Medical Weight Management for Type 2 Diabetes. · 2015 Source ↗
• Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. · 2014 Source ↗
• Airway dysfunction in obesity: response to voluntary restoration of end expiratory lung volume. · 2014 Source ↗
• Role of bariatric surgery as treatment for type 2 diabetes in patients who do not meet current NIH criteria: a systematic review and meta-analysis. · 2013 Source ↗
• Surgical strategies that may decrease leak after laparoscopic sleeve gastrectomy: a systematic review and meta-analysis of 9991 cases. · 2013 Source ↗
• Tests of correlation between immediate postoperative gastroduodenal transit times and weight loss after laparoscopic sleeve gastrectomy. · 2012 Source ↗
• Frequencies of obesity susceptibility alleles among ethnically and racially diverse bariatric patient populations. · 2013 Source ↗
• Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? A pilot randomized study. · 2012 Source ↗
• Laparoscopic "gastrojejunal sleeve reduction" as a revision procedure for weight loss failure after roux-en-y gastric bypass. · 2011 Source ↗
• Laparoscopic sleeve gastrectomy: does bougie size affect mean %EWL? Short-term outcomes. · 2008 Source ↗
• Laparoscopic revision of gastrogastric stricture with a transoral circular stapler. · 2007 Source ↗
• Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. · 2007 Source ↗
• Laparoscopic hiatal hernia repair and repeat sleeve gastrectomy for gastroesophageal reflux disease after duodenal switch. · 2008 Source ↗
• Laparoscopic conversion of failed gastric bypass to duodenal switch: technical considerations and preliminary outcomes. · 2007 Source ↗
• Comparison of outcomes after laparoscopic adjustable gastric banding in African-Americans and whites. · 2006 Source ↗
• Objective comparison of complications resulting from laparoscopic bariatric procedures. · 2006 Source ↗
• Laparoscopic bariatric surgery in super-obese patients (BMI>50) is safe and effective: a review of 332 patients. · 2005 Source ↗

Source-reported information; confirm current details directly.

Insurance reported

Reported in source records. Confirm the exact plan, network and procedure with the practice and insurer. Logos identify brands; they do not establish participation.